Management

Our difference is our team of experts

Our leadership brings extensive scientific, medical, financial and regulatory experience, so every client and every project benefits from deep insight into companion and in vitro diagnostics.

Leadership

Meet the management team

PHILIP D. COTTER

Principal

Philip D. Cotter

PhD, FACMG, FFSc (RCPA)

MATHEW W. MOORE

Principal

Mathew W. Moore

PhD

SHELLY GUNN

Chief Medical Officer

Shelly Gunn

MD, PhD, FCAP

BOBBIE FORESTA

Chief Financial Officer

Bobbie Foresta

Finance and operations

AMBICA BHANDARI

Director, Research and Development

Ambica Bhandari

PhD

MARTIN SELLERS

VP, Regulatory Affairs

Martin Sellers

Regulatory affairs

Scientific depth

Molecular genetics, assay development and laboratory direction across oncology, inherited disease and infectious disease.

Medical and regulatory insight

Board-certified pathology leadership and dedicated regulatory affairs experience with FDA submissions.

Collaborative by design

A quality-focused team that works as an extension of yours, from first conversation through approval.

Put our experience to work on your program

Connect with our team to discuss your diagnostic development goals.